These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18584174)

  • 21. Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo.
    Yang Y; Che Y; Zhao Y; Wang X
    Int Immunopharmacol; 2019 Apr; 69():279-288. PubMed ID: 30743204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
    Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
    J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced generation of cytotoxic T lymphocytes by heat shock protein 70 fusion proteins harboring both CD8(+) T cell and CD4(+) T cell epitopes.
    Takemoto S; Nishikawa M; Guan X; Ohno Y; Yata T; Takakura Y
    Mol Pharm; 2010 Oct; 7(5):1715-23. PubMed ID: 20695521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping T and B cell epitopes in sperm protein 17 to support the development of an ovarian cancer vaccine.
    Xiang SD; Gao Q; Wilson KL; Heyerick A; Plebanski M
    Vaccine; 2015 Nov; 33(44):5950-9. PubMed ID: 26263201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses.
    Xie Y; Chen Y; Ahmed KA; Li W; Ahmed S; Sami A; Chibbar R; Tang X; Tao M; Xu J; Xiang J
    Cancer Gene Ther; 2013 Oct; 20(10):590-8. PubMed ID: 24052129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors.
    Hanson HL; Kang SS; Norian LA; Matsui K; O'Mara LA; Allen PM
    J Immunol; 2004 Apr; 172(7):4215-24. PubMed ID: 15034034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
    Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium.
    Tanaka K; Enomoto N; Uehara M; Furuhashi K; Sakurai S; Yasui H; Karayama M; Hozumi H; Suzuki Y; Fujisawa T; Inui N; Nakamura Y; Nagata T; Suda T
    Microbiol Immunol; 2020 Oct; 64(10):666-678. PubMed ID: 32786043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacy.
    Masuko K; Wakita D; Togashi Y; Kita T; Kitamura H; Nishimura T
    Immunol Lett; 2015 Jan; 163(1):102-12. PubMed ID: 25479286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A tumor lysate is an effective vaccine antigen for the stimulation of CD4(+) T-cell function and subsequent induction of antitumor immunity mediated by CD8(+) T cells.
    Kawahara M; Takaku H
    Cancer Biol Ther; 2015; 16(11):1616-25. PubMed ID: 26391871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.
    Oran AE; Robinson HL
    J Immunol; 2003 Aug; 171(4):1999-2005. PubMed ID: 12902504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A surfactin cyclopeptide of WH1fungin used as a novel adjuvant for intramuscular and subcutaneous immunization in mice.
    Gao Z; Wang S; Qi G; Pan H; Zhang L; Zhou X; Liu J; Zhao X; Wu J
    Peptides; 2012 Nov; 38(1):163-71. PubMed ID: 22982610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
    Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
    J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Essential roles of tumor-derived helper T cell epitopes for an effective peptide-based tumor vaccine.
    Wang L; Miyahara Y; Kato T; Wang L; Aota T; Kuribayashi K; Shiku H
    Cancer Immun; 2003 Nov; 3():16. PubMed ID: 14629132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency.
    Hung CF; Tsai YC; He L; Wu TC
    Mol Ther; 2007 Jun; 15(6):1211-9. PubMed ID: 17356542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responses.
    Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Chibbar R; Wei Y; Liu Q; Xiang J
    Vaccine; 2011 Apr; 29(19):3538-47. PubMed ID: 21406265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination.
    Ahrends T; Bąbała N; Xiao Y; Yagita H; van Eenennaam H; Borst J
    Cancer Res; 2016 May; 76(10):2921-31. PubMed ID: 27020860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.